RPID
NASDAQ · Life Sciences Tools & Services
Rapid Micro Biosystems Inc-A
$3.87
+0.19 (+5.16%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 54.93M | 48.80M | 45.04M |
| Net Income | 7.22M | 7.65M | 7.46M |
| EPS | — | — | — |
| Profit Margin | 13.1% | 15.7% | 16.6% |
| Rev Growth | +2.1% | +18.7% | +19.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 42.05M | 38.69M | 38.35M |
| Total Equity | 118.70M | 134.82M | 132.50M |
| D/E Ratio | 0.35 | 0.29 | 0.29 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 11.16M | 9.93M | 10.62M |
| Free Cash Flow | 4.30M | 5.64M | 3.34M |